Avicenna.AI

About

Avicenna.AI is a medical imaging AI company based in France, founded in 2018. The company specializes in deep learning solutions for emergency radiology and incidental findings detection from CT images. Its goal is to accelerate diagnosis, prioritize critical cases, and improve patient outcomes. Co-founded by Cyril Di Grandi and Dr. Peter Chang, Avicenna.AI focuses on enhancing clinical workflows through its CINA (Comprehensive and Integrated Neural networks Approach) portfolio. The company offers a centralized platform called AVI, launched in November 2025, which provides fast access to imaging AI solutions for hospitals, healthcare networks, and teleradiology groups. AVI features plug-and-play deployment, automatic workflow embedding, and scalability. Avicenna.AI's core products include applications for detecting life-threatening conditions such as aortic dissection, pulmonary embolism, and intracerebral hemorrhage. These tools are designed to reduce interpretation time, boost radiologist productivity, and optimize patient management by enabling early detection and efficient resource allocation.